Tyra Biosciences Inc 's

• TYRA's Stock Performance relative to its Competitors

Zymeworks Inc Share Performance +3.25% Over The Past 5 Days

Zymeworks Inc Profile Zymeworks Inc is a biotechnology company that operates on a licensing and collaboration business model. They primarily generate revenue through partnerships and collaborations with pharmaceutical and biotechnology companies, providing access to their proprietary drug development platform and expertise in protein engineering. This enables them to advance the development of novel bi-specific antibodies and therapeutic proteins for the treatment of various diseases and medical conditions. More about Zymeworks Inc 's Market Share

Olema Pharmaceuticals Inc Share Performance +29.36% One Year

Olema Pharmaceuticals Inc Profile Olema Pharmaceuticals Inc.'s business model focuses on the research, development, and commercialization of innovative cancer therapies. More about Olema Pharmaceuticals Inc 's Market Share

Nextcure Inc Share Performance +28.41% Over The Past 5 Days

Nextcure Inc Profile NextCure Inc is a biopharmaceutical company that operates with a unique business model. They focus on discovering and developing novel immunomedicines to treat various forms of cancer and other immune-related diseases. With a focus on developing innovative therapies that target immune cells, NextCure aims to provide effective and personalized treatment options for patients in need. More about Nextcure Inc 's Market Share

Nuvalent Inc Share Performance +18.03% This Quarter

Nuvalent Inc Profile Nuvalent Inc's business model entails developing innovative pharmaceutical solutions utilizing its proprietary technology and expertise. More about Nuvalent Inc 's Market Share

Nurix Therapeutics Inc Share Performance +163.77% One Year

Nurix Therapeutics Inc Profile Nurix Therapeutics Inc's business model involves developing targeted protein degradation therapies to treat diseases by modulating the body's cellular protein levels. More about Nurix Therapeutics Inc 's Market Share

Sources: Tyra Biosciences Inc’s official press releases and regulatory filings; CSIMarket.com’s market research; and the financial filings and press releases of other companies cited in this report.
Updated on: Sunday, September 6, 2026 6:18 PM
Focus of this report: publicly traded companies.
For your research, we’ve provided 10 tables on Tyra Biosciences Inc versus competitors, including market share analysis.
You can find them in the navigation menu under Competition.
To download the tables, please subscribe.